Cargando…

Management of Epstein–Barr Virus Infection and Post-Transplant Lymphoproliferative Disorder in Pediatric Liver Transplantation

With the advancement of immunosuppressive strategies, the outcome of liver transplantation during childhood has dramatically improved. On the other hand, Epstein–Barr virus (EBV) infection and associated post-transplant lymphoproliferative diseases (PTLD), such as malignant lymphoma, are serious com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okamoto, Tatsuya, Okajima, Hideaki, Uebayashi, Elena Yukie, Ogawa, Eri, Yamada, Yosuke, Umeda, Katsutsugu, Hiramatsu, Hidefumi, Hatano, Etsurou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031649/ https://www.ncbi.nlm.nih.gov/pubmed/35456259 http://dx.doi.org/10.3390/jcm11082166

Ejemplares similares

The New Challenge in Pediatric Liver Transplantation: Chronic Antibody-Mediated Rejection
por: Uebayashi, Elena Yukie, et al.
Publicado: (2022)

Post‐transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants
por: Tajima, Tetsuya, et al.
Publicado: (2021)

Two Cases of Possible Exacerbation of Chronic Rejection After Anti-SARS-CoV-2 Messenger RNA Vaccination: A Case Report
por: Okamoto, Tatsuya, et al.
Publicado: (2023)

Effects of Adding Congested Segment IV to the Left Lateral Graft on Short-term Outcomes in Pediatric Living-donor Liver-transplant Recipients
por: Aoki, Hikaru, et al.
Publicado: (2023)

Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia
por: Hotta, Masaaki, et al.
Publicado: (2018)

Case Report: A Case of Epstein-Barr Virus-Associated Acute Liver Failure Requiring Hematopoietic Cell Transplantation After Emergent Liver Transplantation
por: Nakajima, Koji, et al.
Publicado: (2022)

Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients
por: Chang, Yeh-Chung, et al.
Publicado: (2022)

Persistent Epstein-Barr viral load in Epstein-Barr viral naïve pediatric heart transplant recipients: Risk of late-onset post-transplant lymphoproliferative disease
por: Das, Bibhuti, et al.
Publicado: (2016)

Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia
por: Hyun, Hyesun, et al.
Publicado: (2019)

Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients
por: Baldanti, Fausto, et al.
Publicado: (2011)

Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation
por: Feuillet, S., et al.
Publicado: (2009)

Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatment
por: Shahid, Sanam, et al.
Publicado: (2021)

Erratum: Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia
por: Hyun, Hyesun, et al.
Publicado: (2020)

Epstein-Barr virus-associated monomorphic post-transplant lymphoproliferative disorder after pediatric kidney transplantation: A case report
por: Wang, Zhen, et al.
Publicado: (2021)

Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring
por: Salmona, Maud, et al.
Publicado: (2020)

Epstein-Barr virus induced post-transplant lymphoproliferative disorder presenting with unilateral retinal involvement
por: Adam, Mainguy, et al.
Publicado: (2021)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
por: Navari, Mohsen, et al.
Publicado: (2014)

Management of Epstein–Barr virus-related post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation
por: Liu, Li, et al.
Publicado: (2020)

Case of primary intraocular lymphoproliferative disorder caused by Epstein–Barr Virus
por: Ban, Yumiko, et al.
Publicado: (2020)

Late Onset Epstein Barr Virus Seropositive Posttransplant Lymphoproliferative Disorder in Two Renal Transplant Receivers
por: Paydaş, Saime, et al.
Publicado: (2013)

Epstein-Barr Virus Positive B-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
por: Ishikawa, Eri, et al.
Publicado: (2021)

A Case of Epstein-Barr Virus–Associated Leiomyosarcoma Concurrently With Posttransplant Lymphoproliferative Disorders After Renal Transplantation
por: Aida, Naohiro, et al.
Publicado: (2019)

Biological Difference Between Epstein–Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact
por: Ferla, Valeria, et al.
Publicado: (2020)

X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
por: Mukai, Takeo, et al.
Publicado: (2023)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Strategy of pre-emptive management of Epstein-Barr virus post-transplant lymphoproliferative disorder after stem cell transplantation: results of European transplant centers survey
por: Gil, Lidia, et al.
Publicado: (2012)

Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes
por: Fujimoto, Ayumi, et al.
Publicado: (2020)

Epstein-Barr virus-positive post-transplant lymphoproliferative disordepresenting as hematochezia and enterobrosis in renal transplant recipients in China: A report of two cases
por: Sun, Ze-Jia, et al.
Publicado: (2019)

Epstein-Barr Virus-Negative Post-Transplant Lymphoproliferative Diseases: Three Distinct Cases from a Single Center
por: Bakanay, Şule Mine, et al.
Publicado: (2014)

Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders
por: Sawada, Akihisa, et al.
Publicado: (2018)

Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy
por: Inoue, Hiroaki, et al.
Publicado: (2020)

Methyl-qPCR: a new method to investigate Epstein–Barr virus infection in post-transplant lymphoproliferative diseases
por: Borde, Chloé, et al.
Publicado: (2022)

Case Report: Non-negligible Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in a lung transplant recipient
por: Hu, Juan, et al.
Publicado: (2023)

PB2421: EPSTEIN-BARR VIRUS-ASSOCIATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE: RESULTS OF A DELPHI STUDY IN SPAIN.
por: Sureda, Anna, et al.
Publicado: (2023)

Haploidentical hematopoietic cell transplant recipient presents with late‐onset Epstein Barr virus‐associated posttransplant lymphoproliferative disorder
por: Braun, Adam, et al.
Publicado: (2023)

Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.
por: Chappuis, B B, et al.
Publicado: (1990)

Epstein–Barr virus-positive T/NK-cell lymphoproliferative disorders
por: Cai, Qingqing, et al.
Publicado: (2015)

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
por: Kim, Wook Youn, et al.
Publicado: (2019)

Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions
por: Shiraiwa, Sawako, et al.
Publicado: (2020)

1091. Incidence of Post-Transplant Lymphoproliferative Disorders among Epstein-Barr Virus Donor Positive, Recipient Negative Adult Solid Organ Transplant Recipients
por: Limaye, Abhijit P, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pp7krt29a9rpo8u6en7g5i4tic